Home > Press > Xradia Raises $7 Million in Venture Capital Funding Led by Harris & Harris Group
Abstract:
Xradia, Inc. today announced the closing of a $7.0 million equity in a series D financing round. Major investors included Harris & Harris Group, Inc. an unnamed strategic investor and a prior round investor.
Xradia designs, manufactures and sells a suite of ultra high resolution 3D x-ray microscopes and fluorescence imaging systems capable of nondestructive imaging of internal structures at micrometer and nanometer scale. Important applications include 3D imaging of advanced semiconductor IC's and packages as well as biological specimens ranging from single cells to small animals. Detailed information about Xradia can be found on its website at http://www.xradia.com .
####
About Xradia
Since its formation in 2000, Xradia has become recognized as the leading supplier of high performance x-ray 3D imaging solutions. The company has experienced rapid revenue growth over the last two years and achieved profitability in 2006. “This equity financing will enable the company to accelerate its penetration into new market segments while better serving its rapidly expanding semiconductor, biomedical and nanotechnology customer base. It will also enable the company to develop and introduce new, market focused products that leverage our core technologies,” commented Dr. Wenbing Yun, president, CEO, and co-founder of Xradia.
For more information, please click here
Contacts:
Xradia, Inc.
Wenbing Yun
925-288-1228
Copyright © Business Wire
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Tools
Turning up the signal November 8th, 2024
Quantum researchers cause controlled ‘wobble’ in the nucleus of a single atom September 13th, 2024
Faster than one pixel at a time – new imaging method for neutral atomic beam microscopes developed by Swansea researchers August 16th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||